MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 146 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,413,400 | -63.1% | 85,000 | -41.6% | 3.49% | -70.3% |
| Q2 2023 | $33,633,600 | +49.3% | 145,600 | +56.6% | 11.75% | +58.0% |
| Q1 2023 | $22,530,180 | +10.9% | 93,000 | +32.9% | 7.44% | -6.7% |
| Q4 2022 | $20,317,500 | +78.6% | 70,000 | -60.0% | 7.97% | +151.0% |
| Q3 2022 | $11,373,000 | +58.9% | 175,000 | +75.0% | 3.17% | +5.2% |
| Q2 2022 | $7,158,000 | -2.7% | 100,000 | +33.3% | 3.02% | +156.3% |
| Q1 2022 | $7,359,000 | +33.6% | 75,000 | +15.4% | 1.18% | -41.2% |
| Q4 2021 | $5,508,000 | +890.6% | 65,000 | +1200.0% | 2.00% | +578.0% |
| Q4 2020 | $556,000 | – | 5,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |